Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.



Elizabeth Williams
CEO and co-founder, Hemideina
Talk to the deal team
Related deals
iwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn moreChequers Capital has acquired Gourmet Italian Food to strengthen presence in the ready meals sector
Chequers Partenaires S.A., acting as the management company of the private equity fund Chequers Capital XVIII SLP, together with management, has completed the acquisition of 100% of the share capital of Gourmet Italian Food S.p.A. (GIF). The company was previously owned by Alcedo SGR S.p.A. through the Alcedo IV Fund, FVS SGR S.p.A. through the Sviluppo PMI Fund, and minority shareholders.
Learn morePharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Learn more